The Covid Consortium

The COVID Consortium brings the critical and necessary resources of multiple CLIA certified, CAP and COLA accredited medium and high complexity laboratories, clinicians and technology together to allow the delivery of a consistent COVID-19 test with equally consistent result delivery.

favicon

Who We Are

In Mid March, as the COVID-19 crisis continued in the U.S., one thing became clear to the medical staff at CopernicusMD; either States didn’t desire mass testing for COVID-19 infection or, they simply couldn’t organize it. 

It was puzzling to think that with the resources of the Federal and State governments on both an academic and financial level that broad-based testing in every state could not be mobilized.  So the Medical team at CopernicusMD got to work.

Mission

The mission of the COVID Consortium has two critical priority points.

We recognize the need for reliable, clinically valid testing at scale.

We recognize the need for broad based COVID-19 testing at the employer level to support the re-opening of the American economy.

Latest in the News

Get the latest news for your business from the experts.

  • Cases in the U.S.
    on August 9, 2022 at 5:06 pm

    CDC COVID Data Tracker - Cases and Deaths by State

  • Selected Adverse Events Reported after COVID-19 Vaccination
    on August 8, 2022 at 4:00 am

    COVID-19 vaccines are safe and effective. Millions of people in the United States have received COVID-19 vaccines, and these vaccines will undergo the most intensive safety monitoring in U.S. history. CDC recommends you get a COVID-19 vaccine as soon as you are eligible. Adverse events described on this page have been reported to the Vaccine Adverse Event Reporting System (VAERS).

  • COVID Data Tracker Weekly Review
    on August 5, 2022 at 4:00 am

    A review of the week's key data from CDC's COVID Data Tracker, narrative interpretations, and visualizations.

  • Treatments Your Healthcare Provider Might Recommend for Severe Illness
    on August 5, 2022 at 4:00 am

    This page provides a broad overview of therapies that are currently recommended for COVID-19 treatment. The FDA can issue emergency use authorizations (EUAs) to allow healthcare providers to use products that are not yet approved, or are approved for other uses, to treat patients with COVID-19 if certain legal requirements are met. The National Institutes of Health (NIH) has developed and regularly updates Treatment Guidelines to help guide healthcare providers caring patients with COVID-19. Any treatments that are used for COVID-19 should be under the care of a healthcare provider.

  • Possible Side Effects After Getting a COVID-19 Vaccine
    on August 5, 2022 at 4:00 am

    COVID-19 vaccination will help protect you from getting COVID-19. Learn about possible side effects and some helpful tips to relieve side effects.

  • Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET)
    on August 4, 2022 at 4:00 am

    Learn about hospital surveillance (rates) and how that information helps find who is most at risk for severe illness and death, including important demographic information